Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.64 |
| ▸ | CDC25B | P30305 | 2/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | TSHR | P16473 | 1/20 | 0.64 |
| ▸ | ATM | Q13315 | 1/20 | 0.64 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | FADS1 | O60427 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12955828 | 0.98 | ALDH1A1 (0.62) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL12193003 | 0.97 | ALDH1A1 (0.64) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL29432319 | 0.95 | ALDH1A1 (0.70) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL1034201 | 0.95 | ALDH1A1 (0.70) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL13175115 | 0.92 | ALDH1A1 (0.54) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL30473802 | 0.91 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL12955673 | 0.91 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL4634959 | 0.91 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL12955735 | 0.91 | ALDH1A1 (0.57) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 | |
| SCHEMBL27755617 | 0.90 | ALDH1A1 (0.79) | ALDH1A1HSD17B10CDC25BTP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1951842-B1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2016-07-27 | — | — | EP | disclosed |
| US-8501046-B2 | Use of rylene derivatives as photosensitizers in solar cells | BASF SE (DE) | 2013-08-06 | — | — | US | disclosed |
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | MAX-PLANCK-GESEL. ZUR FOERDERUNG DER WISSEN. E.V. (DE) | 2012-11-08 | — | — | US | disclosed |
| US-8231809-B2 | Solid p-semiconductors may also be used in the inventive dye-sensitized solar cells without increasing the cell resistance, since the rylene derivatives absorb strongly and therefore require only thin n-semiconductor layers | BASF AKTIENGESELLSCHAFT (DE) | 2012-07-31 | — | — | US | disclosed |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | BASF SE (DE) | 2008-10-30 | — | — | US | disclosed |
| EP-1951842-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2008-08-06 | — | — | EP | disclosed |
| WO-2007054470-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | BASF SE (DE) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007020804-A1 | ARYLAMINE COMPOUND AND SYNTHETIC METHOD THEREOF | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2007-02-22 | — | — | WO | disclosed |
| US-20070037011-A1 | Arylamine compound and synthetic method thereof | SEMICONDUCTOR ENERGY LABORATORY CO. (JP) | 2007-02-15 | — | — | US | disclosed |
| US-20070037011-A1 | Arylamine compound and synthetic method thereof | SEMICONDUCTOR ENERGY LABORATORY CO. (JP) | 2007-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070037011-A1 | Arylamine compound and synthetic method thereof | AHR, CYP2A13, ARNT | ALDH1A1 502/4885HSD17B10 358/4885CDC25B 3319/4885 |
| US-20120283432-A1 | USE OF RYLENE DERIVATIVES AS PHOTOSENSITIZERS IN SOLAR CELLS | NR2E3, NR2E1, NR1D2 | ALDH1A1 4248/4885HSD17B10 1009/4885CDC25B 1292/4885 |
| US-20080269482-A1 | Use of Rylene Derivatives as Photosensitizers in Solar Cells | NR2E3, NR2E1, NR1D2 | ALDH1A1 4269/4885HSD17B10 974/4885CDC25B 1332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.